Cargando…

Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: a case report

BACKGROUND: Coronary vasospasm is an increasingly recognized cause of myocardial infarction or myocardial ischaemia in patients without obstructive coronary artery disease. A thorough medication review may identify drugs or toxins that could trigger coronary vasospasm. This case provides mechanistic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mikhail, Philopatir, Rogers, James, Forsyth, Cecily, Ford, Thomas J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323061/ https://www.ncbi.nlm.nih.gov/pubmed/34345762 http://dx.doi.org/10.1093/ehjcr/ytab076

Ejemplares similares

Proteasome Inhibitors for the Treatment of Multiple Myeloma
por: Ito, Shigeki
Publicado: (2020)

Rituximab-Induced Coronary Vasospasm
por: Lee, Linda, et al.
Publicado: (2012)

Capecitabine-Induced Coronary Vasospasm
por: Henry, Danish, et al.
Publicado: (2016)

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone
por: Erath, Alexandra, et al.
Publicado: (2020)

New proteasome inhibitors in the treatment of multiple myeloma
por: Hungria, Vania Tietsche de Moraes, et al.
Publicado: (2019)

Coronary vasospasm induced by cisplatin for seminoma
por: Sasaki, Wataru, et al.
Publicado: (2019)

Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
por: Zhang, Hua, et al.
Publicado: (2022)

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
por: Acosta-Alvear, Diego, et al.
Publicado: (2015)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
por: Merin, Noah M., et al.
Publicado: (2014)

Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
por: Ramirez, Krista G.
Publicado: (2017)

Misoprostol: Acute coronary vasospasm: case report
Publicado: (2021)

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
por: Gu, Yanyan, et al.
Publicado: (2020)

Therapeutic implications of mitochondrial stress–induced proteasome inhibitor resistance in multiple myeloma
por: Sharma, Aditi, et al.
Publicado: (2022)

Fluorouracil/oxaliplatin: Coronary vasospasm and neutropenia: case report
Publicado: (2019)

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
por: Kubiczkova, Lenka, et al.
Publicado: (2014)

Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma
por: Zhou, Jianbiao, et al.
Publicado: (2019)

The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma
por: Paradzik, Tina, et al.
Publicado: (2021)

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma
por: Heynen, Guus J. J. E., et al.
Publicado: (2022)

Multivessel Coronary Artery Vasospasm-Induced Takotsubo Cardiomyopathy
por: Patel, Vishal I., et al.
Publicado: (2022)

Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
por: Haney, Staci L., et al.
Publicado: (2022)

Depression with Panic Episodes and Coronary Vasospasm
por: Vidovich, Mladen I., et al.
Publicado: (2009)

Postpartum Coronary Vasospasm with Literature Review
por: Koneru, Jayanth, et al.
Publicado: (2014)

Coronary Artery Vasospasm in Patients With Eosinophilia
por: Backhouse, Brendan, et al.
Publicado: (2023)

The role of computed tomography coronary angiography in multi-vessel coronary vasospasm: a case report
por: Tomlinson, James S, et al.
Publicado: (2021)

Coronary vasospasm induced by painful compression of the brachial artery following coronary angiography
por: Kraaijeveld, A. O., et al.
Publicado: (2013)

Novel Agents for the Treatment of Multiple Myeloma: Proteasome Inhibitors and Immunomodulatory Agents
por: Kurtin, Sandra E., et al.
Publicado: (2013)

Pulmonary Nocardiosis in a Multiple Myeloma Patient Treated with Proteasome Inhibitors
por: Mendonca, Nikolai P., et al.
Publicado: (2016)

MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
por: Qiang, Ya-Wei, et al.
Publicado: (2018)

The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells
por: Shalem-Cohavi, Naama, et al.
Publicado: (2019)

Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
por: Chen, John H., et al.
Publicado: (2017)

Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance
por: Weir, Philip, et al.
Publicado: (2023)

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma
por: Huang, Hector H., et al.
Publicado: (2020)

5-Fluorouracil–Induced Coronary Vasospasm
por: Arya, Sumedha, et al.
Publicado: (2018)

Coronary vasospasm-induced polymorphic ventricular tachycardia: a case report and literature review
por: Tan, Nigel S, et al.
Publicado: (2018)

Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature
por: Xu, Nengwen, et al.
Publicado: (2021)

Coronary Artery Vasospasm
por: Song, Jae-Kwan
Publicado: (2018)

Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
por: WADA, NAOKO, et al.
Publicado: (2014)

Severe Coronary Vasospasm Complicated with Ventricular Tachycardia
por: Acar, Göksel, et al.
Publicado: (2014)

5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms
por: Faheem, Beenish, et al.
Publicado: (2022)

Case report - coronary vasospasm in transplanted heart: a puzzling phenomenon
por: Pagnoni, M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ggmnqgdfl8teahm4a8dq6jqhbr